Anti-XIAP Antibody

Manufactured by Antibodies.com as part of their Primary Antibodies portfolio, this polyclonal reagent is raised in rabbit and targets X-linked inhibitor of apoptosis protein (XIAP), a key regulator of caspase activity and programmed cell death. The antibody was generated against a synthetic peptide derived from the human XIAP sequence surrounding the non-phosphorylation site at serine 87, and it recognises endogenous levels of the target. Affinity purification from rabbit antiserum using an epitope-specific immunogen delivers a reagent supplied at 1 mg/mL in a PBS buffer containing 50% glycerol, 0.5% BSA and 0.02% sodium azide, with the unconjugated IgG isotype offered in a 50 µL vial. The antibody has been validated for Western blotting (WB), immunohistochemistry (IHC) and ELISA, and it cross-reacts with samples from human, mouse and rat, supporting broad use across apoptosis, cancer-biology and neurodegeneration research workflows. For best stability, the vial should be stored at −20 °C for continuous use, with the lead time quoted at six to nine business days. The product is identified by part number A36048, allowing researchers to source the same clone from authorised distributors while benefiting from consistent lot-to-lot performance and the technical support associated with the Antibodies.com catalogue.